Your browser doesn't support javascript.
loading
Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens.
Limonciel, Alice; van Breda, Simone G; Jiang, Xiaoqi; Tredwell, Gregory D; Wilmes, Anja; Aschauer, Lydia; Siskos, Alexandros P; Sachinidis, Agapios; Keun, Hector C; Kopp-Schneider, Annette; de Kok, Theo M; Kleinjans, Jos C S; Jennings, Paul.
Afiliación
  • Limonciel A; Division of Molecular and Computational Toxicology, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • van Breda SG; Division of Physiology, Department of Physiology and Medical Physics, Medical University of Innsbruck, Innsbruck, Austria.
  • Jiang X; Department of Toxicogenomics, GROW-School for Oncology and Development Biology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Tredwell GD; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wilmes A; Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Aschauer L; Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia.
  • Siskos AP; Division of Molecular and Computational Toxicology, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Sachinidis A; Division of Physiology, Department of Physiology and Medical Physics, Medical University of Innsbruck, Innsbruck, Austria.
  • Keun HC; Division of Physiology, Department of Physiology and Medical Physics, Medical University of Innsbruck, Innsbruck, Austria.
  • Kopp-Schneider A; Brookes Innovation Hub, Orbit Discovery, Oxford, United Kingdom.
  • de Kok TM; Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.
  • Kleinjans JCS; Institute of Neurophysiology and Center for Molecular Medicine Cologne (CMMC), University of Cologne (UKK), Cologne, Germany.
  • Jennings P; Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Front Genet ; 9: 558, 2018.
Article en En | MEDLINE | ID: mdl-30559759
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Genet Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Genet Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza